JPRN-UMIN000017967已完成2 期
Clinical study of gemcitabine plus docetaxel in patient with refractory bone and soft tissue sarcomas - GEM+DTX in patient with sarcomas
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patient with severe liver or renal dysfunction Patient with severe interstitial pneumonitis PS4 Pregnant woman Patient who was decided as incompatible by the principal investigator of this study
研究者
相似试验
进行中（未招募）
不适用
A study to know the effects of a chemotherapy medicine named Gemcitabine plus Docetaxel combination in patients of recurrent or advanced soft tissue sarcomaCTRI/2018/08/015291A
进行中（未招募）
不适用
Simultaneous Study of Gemcitabine-Docetaxel Combination adjuvant treatment, as well as Biological Targeted TreatmentSUCCESS B-Trial - SUCCESS-BPatientinnen mit primärem epithelialem invasivem MammakarzinomEUCTR2007-001094-29-DEKlinikum der LM
进行中（未招募）
不适用
Simultaneous Study of Gemcitabine-Docetaxel Combination adjuvant treatment, as well as Extended Bisphosphonate and Surveillance-Trial SUCCESS-Trial - SUCCESSThis is an open-label, multicenter, 2x2 factorial design, randomized controlled, Phase III study comparing the time to recurrence after randomisation in patients with early primary breast cancer.EUCTR2005-000490-21-DE1. Frauenklinik der LMU- Innenstadt
进行中（未招募）
1 期
A fase I/II trial with docetaxel and gemcitabine in hormone refractory prostate cancerHormone fractory prostate cancerEUCTR2004-002353-31-DKOrganisation name was not entered60
招募中
2 期
Study of gemcitabine docetaxel in synovial sarcoma in relapsed metastatic settingCTRI/2020/02/023612Department of Medical Oncology